Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

27 Jan 2010 12:13

RNS Number : 2048G
Standard Life Euro Pri Eqty Tst PLC
27 January 2010
 



Standard Life European Private Equity Trust PLC

Interim management statement

 for the quarter ended 31 December 2009

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 October 2009 to 31 December 2009. This announcement constitutes the Company's first interim management statement for the year ending 30 September 2010 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information as at 31 December 2009 and any material developments up to 27 January 2010. 

Investment objective

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

Benchmark

The Company has no defined benchmark.

Performance

The Company's audited net asset value per ordinary share ("NAV") was 164.9p as at 30 September 2009 (diluted - 163.4p). The Company's NAV as at 31 December 2009 will be announced on or around 17 March 2010. The share price of the Company's ordinary shares was 99.25p as at 31 December 2009, compared to 112.25p as at 30 September 2009, a decline of 11.6% over the quarter. Over the same quarter the MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) both rose 4.8%.

Financial position 

While the quarter ended 31 December 2009 witnessed a slight increase in new investment and realisation activity in the European private equity market from the lows of the first nine months of 2009, this had not impacted the Company's cashflows by the quarter end. The Company funded £12.0 million of draw downs during the quarter (quarter ended 30 September 2009 - £10.5 million) and received £1.7 million of distributions (quarter ended 30 September 2009 - £4.0 million). 

The Company had aggregate outstanding commitments to its 40 private equity fund interests of £194.7 million as at 31 December 2009 (30 September 2009 - £227.8 million). During the period from 1 October 2009 to 31 December 2009 the Company made no new private equity fund commitments.  

As at 31 December 2009 the Company had net indebtedness of £37.8 million (30 September 2008 - net indebtedness of £27.3 million). 

Events and transactions in the period to 27 January 2010

As part of the management of the Company's balance sheet and its outstanding commitments, the Company accepted an offer made to all investors in Apax Europe VII in December 2009, from two large private equity investors, to acquire existing outstanding commitments in that fund. Apax Europe VII is a €11.1 billion private equity fund, which was raised in 2006-07. The investors agreed to acquire €685 million of outstanding commitments in Apax Europe VII from investors in the fund. To that end, the Company has sold €18.6 million of its €31.5 million of existing outstanding commitments in Apax Europe VII to the above investors for an initial nil consideration. 

As a result of the above sale the Company has reduced its original level of participation in any new investments made by Apax Europe VII by 77%, but it will continue to fund the full amount of any draw downs in respect of existing investments. As part of the sale arrangements, accepting investors have agreed to pay 10% of any distributions in excess of a 2.0X aggregate net return on all existing Apax Europe VII investments to the two large investors acquiring the outstanding commitments, should such returns be generated. Save for the above potential profit share, the sale has no impact on the Company's remaining interest in Apax Europe VII.

Further, when the Company sold a number of its private equity fund interests in spring 2009 it was unable, as a result of a restriction on fund transfers, to announce and complete the transfer of part of its fund interest in the CVC Tandem Fund to a European private equity investor on terms agreed with that party. The Company has now completed the formalities regarding that sale, which was of an original commitment of €10.0 million to the CVC Tandem Fund. The sale was completed in January 2010 for an aggregate consideration of £1.9 million, as compared to the 30 September 2009 valuation of that fund interest, increased by subsequent cashflows, of £4.2 million. The fund interest had aggregate outstanding commitments of £3.2 million, from which the Company has now been released. 

Taking account of the above disposals, together with draw downs, distributions, expenses and foreign exchange rate movements from 1 October 2009, the Company's total outstanding commitments and net indebtedness were £183.8 million and £37.5 million respectively as at 26 January 2010. 

Finally, on 27 January 2010 shareholders approved a final dividend for the year ended 30 September 2009 of 0.1p per ordinary share at the Company's annual general meeting. This final dividend will be paid on 29 January 2010.

Commenting at the Company's annual general meeting earlier today, Scott Dobbie CBE, Chairman, said:-

"The last quarter of 2009 saw signs of a pick up in the number of deal opportunities being reviewed by European private equity managers. Moreover, a number of private equity managers are currently considering, or are engaged in, exit discussions for their existing portfolio investments. We anticipate that 31 December 2009 valuations will reflect some of the upward move in listed equity markets in the second half of 2009 and the improving macro-economic environment in the core European economies."

For further information on the statement please contact:-

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 842 of the Income and Corporation Taxes Act 1988. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBDGDBBBDBGGR
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.